Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2022

Fair Value Disclosures [Abstract]

Schedule of Assets Measured at Fair Value on Recurring Basis

The following table sets forth by level within the fair value hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 (in thousands).

	June 30, 2022								December 31, 2021
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets:
Marketable securities - available for sale	$	—	$	39,643	$	—	$	39,643	$	—	$	70,323	$	—	$	70,323
Investment in Cend Therapeutics	$	—	$	—	$	10,000	$	10,000	$	—	$	—	$	—	$	—
	$	—	$	39,643	$	10,000	$	49,643	$	—	$	70,323	$	—	$	70,323